Dr. Anuja Java (she/her/hers) is a transplant nephrologist at Washington University School of Medicine

in St. Louis and Director of Kidney Transplantation at the John Cochran VA medical

center in St. Louis.

Her research focuses on defining the functional consequences of genetic variants

identified in patients with complement-mediated diseases, including atypical hemolytic

uremic syndrome, C3 glomerulopathy, preeclampsia and age-related macular

degeneration. These structure-function evaluations are often used to delineate the risk

of recurrence of disease after a kidney transplant and assist with individualized clinical

decision-making for patients. She has published her work on functional analysis of

complement genetic variants in several high-impact journals. She co-chairs the NIH-

funded Clinical Genome Resource (ClinGen) complement gene curation expert panel.

Her clinical interests include taking care of patients after a kidney transplant, with a

particular emphasis on those at risk for recurrent glomerular diseases. She chairs the

transplant subcommittee in the National VA advisory board.

Dr. Java has served on the American Society of Nephrology career

advancement committee

. She is an elected councilor in Women in Nephrology (WIN). She is co-chair

of the International Society of Nephrology (ISN) Education Working Group for

Complement Pathway Disease Curriculum. She is also recipient of the 2022 National

Kidney Foundation “Award of Excellence” for significant contributions to the field

of kidney

disease and the renal community.

MSC 8126-005-0603A

Telephone: 314-362-8351 (Wash U) / 314-289-6485 (VA)

Fax : 314-362-2713 (Wash U) / 314-289-7012 (VA)

Anuja Java, MD

Annie Hubben, MD